Patients with lesions with diameter ≥ 1 cm showing tumor uptake < 0.5-fold of parotid (which approximately equals < 1.0-fold liver-uptake of [68 Ga]Ga-PSMA-11 that has been used in VISION) should be excluded from receiving 177Lu-PSMA-RLT [97]. The gene discussed is FOLH1; the disease is neoplasm.